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Abstract
HIV-1 particle assembly mediated by viral Gag protein occurs predominantly at plasma membrane. While colocali-
zation of HIV-1 envelope with lipid rich microenvironment have been shown in T cells, the significance of viral pro-
teins modulating envelope association in such microdomains in plasma membrane enriched in
glycosylphosphatidylinositol-anchored proteins in primary CD4
+ T cells that are natural targets of HIV-1 is poorly
understood. Here we show that in primary CD4
+ T cells that are natural targets of HIV-1 in vivo, Gag modulates
HIV-1 envelope association with GM1 ganglioside and CD59 rich cellular compartments as well as with detergent
resistant membranes. Our data strengthen evidence that Gag-Env interaction is important in envelope association
with lipid rafts containing GPI-anchored proteins for efficient assembly onto mature virions resulting in productive
infection of primary CD4
+ T cells.
Findings
Human Immunodeficiency Virus Type 1 (HIV-1) has
been shown to assemble via specialized plasma mem-
brane domains popularly known as lipid rafts [1-6],
which are rich in cholesterol and sphingomyelin within
an ordered structure and plays important role in cell
signaling [7]. Rafts are believed to play an important
role towards facilitating HIV-1 assembly particularly
exploiting acylated residues in viral Gag [1,3,5] and
envelope (Env) [8,9]. However, the precise mechanism
by which lipid rafts functions in targeting viral Env and
Gag to the plasma membrane in infected T cells and
facilitate assembly is not clearly understood. Previously,
Jolly and Sattentau [10] have shown that raft integrity is
critical for Env and Gag co-clustering and assembly in
T-cell conjugates. Thus, mere presence of non raft pro-
teins such as CD45 phosphatase in HIV-1 envelope
glycoprotein while abundant incorporation of raft lipid
components such as ganglioside GM1, glycosylphospha-
tidylinositol (GPI)-anchored proteins Thy-1 and CD59
strongly suggest that HIV-1 specifically buds from rafts
[5,11]. A stable interaction between intracellular
Pr55Gag and the gp41 cytoplasmic domain of envelope
[12] was shown to be important for envelope association
with detergent resistant membranes, incorporation onto
virions and infectivity [13,14]. The precise sequence by
which envelope utilizes cellular machinery in migrating
towards the site of viral assembly is not clearly under-
stood. Glycoproteins of several enveloped viruses, have
been found to contain lipid moieties [15,16] and has
generated notion on the importance of lipid rafts as a
docking site for the assembly of enveloped viruses
[17-22]. Association of HIV-1 envelope with polarized
lipid raft markers GM1 and CD59 was shown to influ-
ence transmission between T cells [10]. Gag has been
s h o w nt op l a ya ni m p o r t a n tr o l ei ne n v e l o p ea s s e m b l y
onto virions, notably by interaction of its p17 matrix
domain with gp41 cytoplasmic domain of envelope
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any medium, provided the original work is properly cited.[14,23-25]. While HIV Gag intrinsically associates with
detergent resistant membranes (DRMs) [5,26], influenza
virus M1 protein transport to DRMs depends on co-
expression of HA and NA glycoproteins [27]. Likewise,
the association of Sendai virus M protein in DRM is
dependent on expression of F or HN protein [28], while
the Rous sarcoma virus M protein requires expression
with the F protein for DRM association [29]. In contrast,
the Measles virus M protein has been shown to associate
DRMs intrinsically independent of other viral proteins
[30]. Motifs in gp41 cytoplasmic domain regulating asso-
ciation of HIV-1 envelope protein with DRM [8] and this
phenomenon is Gag dependent in a T cell line [13] was
previously reported. However, it was not known whether
this phenomenon is cell type-dependent and if it differs
between cell lines and those that are natural targets in
vivo. Moreover, whether DRM association of envelope cor-
roborates with their ability to traffic to classical lipid rafts
was also not known. In the present study we investigated
the role of Gag in intracellular transport of HIV-1 envel-
ope into well defined GPI-anchored proteins such as
CD59 and GM1 (monosialotetrahexosylganglioside) and
its relevance of envelope assembly onto budding virions in
primary CD4
+ T cells. Precisely, we examined whether a
point mutation (L30E) in matrix domain of Gag known
for disrupting Env incorporation [23,31] affects envelope
trafficking to CD59+ compartment in primary CD4
+ T
cells and if this phenomenon has any association with cell-
free infectivity in primary CD4
+ Tc e l l s .
We first examined whether a point mutation (L30E) in
matrix domain of Gag previously reported to abrogate
envelope incorporation, infectivity [23] and DRM asso-
ciation [13] in cell lines affect infectivity and modulate
envelope association with CD59-enriched compartment
in primary CD4
+ T cells which are predominantly the
natural targets in vivo during entire course of HIV-1
infection. CD59 marker was selected as it is linked with
phosphatidylinositol and segregates into rafts. Primary
CD4
+ T cells were purified by negative selection from
whole blood using RosetteSep® Kit (Stem Cell Technolo-
gies Inc.) following manufacturer’s protocol. Briefly,
CD4
+ T Cell Enrichment Cocktail was added at a final
concentration of 50 μl/ml of whole blood and incubated
at room temperature for 20 min. The mixture was
diluted with RPMI/2% Fetal Bovine Serum (GIBCO,
Inc), layered onto Ficoll Hypaque (Sigma, Inc) and cen-
trifuged for 20 min at 1200 × g at room temperature.
The enriched CD4
+ T cells in the interface of density
medium and plasma yielded approximately 98% purity;
subsequently stimulated with phytohemagglutinin (0.5
ug/ml) and interleukin-2 (10-20 U/ml) before infection
with virus stocks. Primary CD4
+ T cells were infected
with equal infectivity titers of VSV-G pseudotyped
pNL4.3 WT and pNL4.3 L30E viruses and the cell
lysates made from CD4
+ T cells infected with wild type
and L30E expressing equal amounts of p24 and gp41
were incubated with anti-gp41 monoclonal antibodies to
immuno-precipitate Env. Briefly, CD4
+ T cells were
lyzed with 1% Triton X-100 in PBS (pH 7.4), and incu-
bated with 1:1 mixture of gp41 monoclonal antibodies
2F5 and 4E10 (1:1000 dilution) for 4 hours at 4°C fol-
lowed by additional 1 hour incubation with Protein A/G
Figure 1 A. L30E Gag confers defective association of Env with CD59-enriched membranes in primary CD4
+ T cells. Primary CD4
+ T cells
infected with VSV-G pseudotyped pNL4.3 and pNL4.3 (L30E) were lyzed and intracellular p55, gp41 and CD59 contents were measured in total
cell lysates (as shown here in upper panels). Cell lysates expressing comparable p55 and gp41 were immunoprecipitated with gp41 antibodies
2F5 and 4E10 as described in the Materials and Methods resolved in 12.5% SDS-PAGE and electrophoretically transferred onto PVDF membrane.
The level of CD59 co-immunoprecipitated with envelope was detected by Western blotting using monoclonal anti-CD59 antibody. B. Defective
incorporation of HIV-1 envelope proteins onto virus particles due to L30E Gag substitution. Equal amounts of cell free virus particles were
resolved in SDS-PAGE and Western blotting done by monoclonal antibodies to gp41 and p24 as described in the text. Note that with L30E gag
mutation, envelope incorporation onto virions is severely abrogated.
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cold PBS and were resolved in 12% SDS-PAGE under
denaturing conditions. Equal amounts of immunopreci-
pitated materials were subjected to 12% SDS-PAGE
under denaturing conditions [32], transferred onto
PVDF membranes and subsequently Western blot assay
done with anti-human CD59 antibody (at 1: 1000 dilu-
tion) to assess the ability of Env association with CD59-
enriched compartment. As shown in Figure 1A, due to
L30E mutation in Gag, Env failed to recruit CD59 in
contrast to pNL4.3 wild type. Our data indicate that the
mutation in Gag MA region (L30E) restricts the interac-
tion between Gag and Env resulting in down modula-
tion of envelope trafficking to GPI-anchored membranes
in primary CD4
+ T cells such as CD59. Moreover, in
order to assess the effect of L30E mutation in p17 gag
on HIV-1 envelope incorporation on virions in primary
CD4
+ T cells, cell-free virus pellets were obtained by
centrifugation as described previously [13]. Equal
amounts of virus particles (p24) were resolved in SDS-
PAGE under denaturing conditions followed by Western
blotting using monoclonal antibodies to p24 (183-H12-
5C) and gp41 (1:1 of 2F5 and 4E10). As shown in Figure
1B, L30E substitution in p17 Gag was found to drasti-
cally affect envelope incorporation onto virus particles
in CD4
+ T cells as expected.
We next assessed if there is any correlation between
disruptions of envelope association with CD59+ com-
partment in primary CD4
+ T cells and its association
with DRM of the same cell type. The DRM assay was
Figure 2 Envelope association with DRM in primary CD4
+ Tc e l l s .A .C D 4
+ T cells infected with VSV-G pseudotyped pNL4.3 and pNL4.3
(L30E) were treated with cold Triton-X 100 and fractionated in sucrose density gradients as described in the text. Gradient fractions were
subsequently probed for envelope with gp41 antibodies 2F5 and 4E10, anti-human CD59 for CD59 and CTxB-HRP for GM1 by SDS-PAGE
followed by Western blotting. B. Density (g/cm
3) of fractions showing DRM and DSM (detergent soluble membrane) fractions [39].
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Briefly, primary CD4
+ T cells infected with VSV-G pseu-
dotyped pNL4.3 WT and pNL4.3 (L30E) were lyzed
with cold 0.5% Triton-X-100 and fractionated through
sucrose density gradient centrifugation in an ultracentri-
fuge (Beckman Coulter Inc) at 1,00,000 × g for 8-12
hours at 4°C. Ten equal fractions were collected and
were examined for presence of gp160, CD59 and GM-1
ganglioside by Western blot using human anti-gp41
monoclonal antibody (2F5) [31] and 4E10 [33], mouse
anti-human CD59 (BD Biosciences Inc) and cholera
toxin conjugated to horse radish peroxidase (HRP)
(Sigma, Inc.) respectively. As shown in Figure 2, L30E
mutation in Gag restricted envelope association with
DRM fractions of CD4
+ T cells in contrast to the wild
type. Our results were further substantiated by the pre-
sence of both CD59 and GM1 in DRM fractions under
same experimental conditions.
In summary, we show the modulatory role of Gag on
envelope association with lipid enriched micro domain
that play an important role in transmission by modulat-
ing envelope assembly onto virus particles in primary
CD4
+ T cells. Despite its close proximity, DRMs isolated
from cells may not necessarily represent the preexisting
rafts in living cells. [34,35]. Hence, GPI anchored pro-
teins because of their raftofilcity often are regarded as
best choice for studying raft association and targeting
[36]. In our present study, in addition to investigate role
of gag in envelope association with DRM, we attempted
to look into GPI-anchored proteins for their high affi-
nity towards lipid raft association [35,37]. The lipid-
binding B subunit of cholera toxin (CTxB), recognizing
GM1 at cell surface in plasma membrane, was used to
study the envelope transport into lipid rafts. Like other
GPI-anchored proteins, these markers were also known
to be associated with DRM [38]. Our data showed that
abrogation of Gag-Env interaction down modulated
envelope transport into CD59 positive compartment in
primary CD4
+ T cells and also failed to associate with
DRM fractions. While viral precursors Gag and Gag-Pol
are synthesized by polysomes in cellular cytoplasm, the
oligomeric envelope protein is synthesized in endoplas-
mic reticulum and post-translationally modulated in the
Golgi apparatus, traverses into the secretory pathway
towards assembling onto budding virions. We envisage
that Gag by acting as cargo transport intermediate carry
envelope protein through trans-golgi route sorting into
domains of lipid rich plasma membrane enable them
assemble onto budding virions in primary CD4
+ T cells.
List of abbreviations
DRM: detergent resistant membrane; GM1: monosialo-
tetrahexosylganglioside; GPI: glycosylphosphatidylinosi-
tol; GHOST: human osteosarcoma cells expressing CD4
and green fluorescent protein; CTxB: cholera toxin-b
subunit.
Acknowledgements
We thank Dr. Paul Clapham, UMASS Medical School, and Worcester, USA for
providing GHOST-CXCR4 cell line and Dr. Bhaskar Saha, National Center for
Cell Science; Pune for help with ultracentrifugation required for DRM assays.
We thank NIH AIDS Reagent and Reference Program for 183-H12-5C
Hybridoma, 2F5 and 4E10 monoclonal antibodies. This study was supported
by a fellowship grant from American Foundation of AIDS Research (amfAR)
to JB (106658-36-RFNT).
Authors’ contributions
JB has designed the study; AP and AG have performed the experiments; AP
and AG helped JB in writing the manuscript. All the authors have read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 4 November 2009
Accepted: 8 January 2010 Published: 8 January 2010
References
1. Campbell SM, Crowe SM, Mak J: Lipid rafts and HIV-1: from viral entry to
assembly of progeny virions. J Clin Virol 2001, 22:217-227.
2. Ding L, Derdowski A, Wang JJ, Spearman P: Independent segregation of
human immunodeficiency virus type 1 Gag protein complexes and lipid
rafts. J Virol 2003, 77:1916-1926.
3. Holm K, Weclewicz K, Hewson R, Suomalainen M: Human
immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag)
associates with membrane domains that are largely resistant to Brij98
but sensitive to Triton X-100. J Virol 2003, 77:4805-4817.
4. Lindwasser OW, Resh MD: Multimerization of human immunodeficiency
virus type 1 Gag promotes its localization to barges, raft-like membrane
microdomains. J Virol 2001, 75:7913-7924.
5. Nguyen DH, Hildreth JE: Evidence for budding of human
immunodeficiency virus type 1 selectively from glycolipid-enriched
membrane lipid rafts. J Virol 2000, 74:3264-3272.
6. Ono A, Freed EO: Plasma membrane rafts play a critical role in HIV-1
assembly and release. Proc Natl Acad Sci USA 2001, 98:13925-13930.
7. Harder T, Engelhardt KR: Membrane domains in lymphocytes - from lipid
rafts to protein scaffolds. Traffic 2004, 5:265-275.
8. Bhattacharya J, Peters PJ, Clapham PR: Human immunodeficiency virus
type 1 envelope glycoproteins that lack cytoplasmic domain cysteines:
impact on association with membrane lipid rafts and incorporation onto
budding virus particles. J Virol 2004, 78:5500-5506.
9. Rousso I, Mixon MB, Chen BK, Kim PS: Palmitoylation of the HIV-1
envelope glycoprotein is critical for viral infectivity. Proc Natl Acad Sci
USA 2000, 97:13523-13525.
10. Jolly C, Sattentau QJ: Human immunodeficiency virus type 1 virological
synapse formation in T cells requires lipid raft integrity. J Virol 2005,
79:12088-12094.
11. Chazal N, Gerlier D: Virus Entry, Assembly, Budding, and Membrane Rafts.
Microbiology and Molecular Biology Reviews 2003, 67:226-237.
12. Wyma DJ, Kotov A, Aiken C: Evidence for a stable interaction of gp41
with Pr55(Gag) in immature human immunodeficiency virus type 1
particles. J Virol 2000, 74:9381-9387.
13. Bhattacharya J, Repik A, Clapham PR: Gag Regulates Association of Human
Immunodeficiency Virus Type 1 Envelope with Detergent-Resistant
Membranes. J Virol 2006, 80:5292-5300.
14. Freed EO, Martin MA: Domains of the human immunodeficiency virus
type 1 matrix and gp41 cytoplasmic tail required for envelope
incorporation into virions. J Virol 1996, 70:341-351.
15. Aloia RC, Tian H, Jensen FC: Lipid composition and fluidity of the human
immunodeficiency virus envelope and host cell plasma membranes. Proc
Natl Acad Sci USA 1993, 90:5181-5185.
Patil et al. Virology Journal 2010, 7:3
http://www.virologyj.com/content/7/1/3
Page 4 of 516. Aloia RC, Jensen FC, Curtain CC, Mobley PW, Gordon LM: Lipid
composition and fluidity of the human immunodeficiency virus. Proc
Natl Acad Sci USA 1988, 85:900-904.
17. Li M, Yang C, Tong S, Weidmann A, Compans RW: Palmitoylation of the
murine leukemia virus envelope protein is critical for lipid raft
association and surface expression. J Virol 2002, 76:11845-11852.
18. Manie SN, Debreyne S, Vincent S, Gerlier D: Measles virus structural
components are enriched into lipid raft microdomains: a potential
cellular location for virus assembly. J Virol 2000, 74:305-311.
19. Ochsenbauer-Jambor C, Miller DC, Roberts CR, Rhee SS, Hunter E:
Palmitoylation of the Rous sarcoma virus transmembrane glycoprotein is
required for protein stability and virus infectivity. J Virol 2001, 75:11544-
11554.
20. Zurcher T, Luo G, Palese P: Mutations at palmitoylation sites of the
influenza virus hemagglutinin affect virus formation. J Virol 1994,
68:5748-5754.
21. Fleming EH, Kolokoltsov AA, Davey RA, Nichols JE, Roberts NJ Jr:
Respiratory syncytial virus F envelope protein associates with lipid rafts
without a requirement for other virus proteins. J Virol 2006, 80:12160-
12170.
22. Lopez LA, Riffle AJ, Pike SL, Gardner D, Hogue BG: Importance of
conserved cysteine residues in the coronavirus envelope protein. J Virol
2008, 82:3000-3010.
23. Freed EO, Martin MA: Virion incorporation of envelope glycoproteins with
long but not short cytoplasmic tails is blocked by specific, single amino
acid substitutions in the human immunodeficiency virus type 1 matrix. J
Virol 1995, 69:1984-1989.
24. Freed EO, Orenstein JM, Buckler-White AJ, Martin MA: Single amino acid
changes in the human immunodeficiency virus type 1 matrix protein
block virus particle production. J Virol 1994, 68:5311-5320.
25. Hourioux C, Brand D, Sizaret PY, Lemiale F, Lebigot S, Barin F, Roingeard P:
Identification of the glycoprotein 41(TM) cytoplasmic tail domains of
human immunodeficiency virus type 1 that interact with Pr55Gag
particles. AIDS Res Hum Retroviruses 2000, 16:1141-1147.
26. Ono A, Freed EO: Role of lipid rafts in virus replication. Adv Virus Res 2005,
64:311-358.
27. Ali A, Avalos RT, Ponimaskin E, Nayak DP: Influenza virus assembly: effect
of influenza virus glycoproteins on the membrane association of M1
protein. J Virol 2000, 74:8709-8719.
28. Ali A, Nayak DP: Assembly of Sendai virus: M protein interacts with F and
HN proteins and with the cytoplasmic tail and transmembrane domain
of F protein. Virology 2000, 276:289-303.
29. Henderson G, Murray J, Yeo RP: Sorting of the respiratory syncytial virus
matrix protein into detergent-resistant structures is dependent on cell-
surface expression of the glycoproteins. Virology 2002, 300:244-254.
30. Manie SN, Debreyne S, Vincent S, Gerlier D: Measles virus structural
components are enriched into lipid raft microdomains: a potential
cellular location for virus assembly. J Virol 2000, 74:305-311.
31. Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A,
Purtscher M, Gruber G, Tauer C, Steindl F, Jungbauer A, Katinger H:
Generation of human monoclonal antibodies against HIV-1 proteins;
electrofusion and Epstein-Barr virus transformation for peripheral blood
lymphocyte immortalization. AIDS Res Hum Retroviruses 1994, 10:359-369.
32. Laemmli UK: Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 1970, 227:680-685.
33. Stiegler G, Kunert R, Purtscher M, Wolbank S, Voglauer R, Steindl F,
Katinger H: A potent cross-clade neutralizing human monoclonal
antibody against a novel epitope on gp41 of human immunodeficiency
virus type 1. AIDS Res Hum Retroviruses 2001, 17:1757-1765.
34. Melkonian KA, Chu T, Tortorella LB, Brown DA: Characterization of proteins
in detergent-resistant membrane complexes from Madin-Darby canine
kidney epithelial cells. Biochemistry 1995, 34:16161-16170.
35. Brown DA: Lipid rafts, detergent-resistant membranes, and raft targeting
signals. Physiology (Bethesda) 2006, 21:430-439.
36. Brown DA, London E: Functions of lipid rafts in biological membranes.
Annu Rev Cell Dev Biol 1998, 14:111-136.
37. Legler DF, Doucey MA, Schneider P, Chapatte L, Bender FC, Bron C:
Differential insertion of GPI-anchored GFPs into lipid rafts of live cells.
Faseb J 2005, 19:73-75.
38. Orlandi PA, Fishman PH: Filipin-dependent inhibition of cholera toxin:
evidence for toxin internalization and activation through caveolae-like
domains. J Cell Biol 1998, 141:905-915.
39. Dolganiuc V, McGinnes L, Luna EJ, Morrison TG: Role of the cytoplasmic
domain of the Newcastle disease virus fusion protein in association with
lipid rafts. J Virol 2003, 77:12968-12979.
doi:10.1186/1743-422X-7-3
Cite this article as: Patil et al.: Evidence that Gag facilitates HIV-1
envelope association both in GPI-enriched plasma membrane and
detergent resistant membranes and facilitates envelope incorporation
onto virions in primary CD4
+ T cells. Virology Journal 2010 7:3.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Patil et al. Virology Journal 2010, 7:3
http://www.virologyj.com/content/7/1/3
Page 5 of 5